Supreme Court Directs 19 States and UTs to Declare Cancer a Notifiable Disease for Early Detection and Uniform Care

Why in News

On 11 August 2026, a bench of the Supreme Court of India comprising Chief Justice of India (CJI) Surya Kant, Justice Joymalya Bagchi, and Justice V Mohana directed the 19 remaining states and Union Territories that had not yet acted to declare cancer a "notifiable disease". The Court found that only 17 of India's 36 states and Union Territories had so far notified cancer, following a parliamentary standing committee recommendation. The Court also asked the Central Government why it had not issued mandatory guidelines to ensure a uniform policy across all states and UTs. All non-compliant states and UTs were directed to file compliance affidavits.

Background

Cancer is one of India's most significant public health challenges. According to data from the Indian Council of Medical Research (ICMR) and the National Cancer Registry Programme (NCRP), India records approximately 14 lakh (1.4 million) new cancer cases annually, with the numbers rising steadily. Despite this burden, there has been no uniform national mechanism compelling healthcare providers and hospitals to report cancer diagnoses to government authorities — a gap that impairs national data collection, early detection programmes, and treatment resource allocation.

A parliamentary standing committee had previously recommended that all states and UTs declare cancer a notifiable disease. However, implementation remained fragmented: by August 2026, only 17 of 36 states and UTs had acted on this recommendation, leaving nearly half the country without a mandatory reporting framework for cancer cases.

In response, renowned surgeon Dr Anurag Srivastava, former Head of the Department of Surgical Disciplines at the All India Institute of Medical Sciences (AIIMS), New Delhi, filed a Public Interest Litigation (PIL) in the Supreme Court, seeking a direction to declare cancer a notifiable disease across the country. The Supreme Court issued notices on 12 December 2025 to the Centre and all states and UTs, and the matter progressed to the August 2026 order.

Current Developments

The Supreme Court bench (CJI Surya Kant, Justice Joymalya Bagchi, Justice V Mohana) heard the case and noted that 17 of 36 states and UTs had already complied. The Court directed the remaining 19 states and UTs to:

1. Consider the parliamentary standing committee's recommendations and take appropriate decisions on declaring cancer a notifiable disease.
2. File compliance affidavits before the Court within a stipulated period, confirming the decisions taken.

The Court also questioned the Centre on why it had not issued mandatory national guidelines to ensure uniformity across all states and UTs, observing that there should be a uniform national policy on cancer notification.

Key Facts

• Case: PIL filed by Dr Anurag Srivastava, former Head, Dept of Surgical Disciplines, AIIMS New Delhi.
• Bench: CJI Surya Kant, Justice Joymalya Bagchi, Justice V Mohana.
• SC notice originally issued: 12 December 2025.
• As of August 2026: 17 of 36 states and UTs had notified cancer as a notifiable disease.
• SC directed 19 remaining states and UTs to comply and file affidavits.
• Constitutional basis: Articles 14 and 21 of the Constitution.
• India has approximately 14 lakh new cancer cases annually (ICMR/NCRP data).
• Common cancers in India: oral/tobacco-related, breast, cervical, lung, colorectal.
• Early detection improves 5-year survival rates significantly for most cancers.

What is a Notifiable Disease?

A notifiable disease is one whose occurrence — upon diagnosis or death — must be mandatorily reported by healthcare providers (doctors, hospitals, laboratories) to the designated government health authority. Once notified:

• Government health departments can track incidence, prevalence, and geographic spread of the disease.
• Resources (drugs, diagnostic equipment, specialists) can be allocated based on real-time disease burden data.
• Early detection and screening programmes can be targeted at high-incidence areas.
• Patients can receive government-sponsored treatment support more systematically.

Historically, notifiable disease lists in India have focussed on communicable diseases (cholera, tuberculosis, dengue, etc.). Including cancer — a non-communicable disease (NCD) — in notifiable disease lists represents a significant evolution in India's public health surveillance approach.

Constitutional Provisions

• Article 21: "No person shall be deprived of his life or personal liberty except according to procedure established by law." The Supreme Court has consistently held that the right to life includes the right to health (e.g., Paschim Banga Khet Mazdoor Samity v. State of West Bengal, 1996) and the right to timely, accessible medical care. Non-notification that delays cancer diagnosis and treatment infringes this right.
• Article 14: Right to equality before law. The PIL argues that patchy notification across states creates unequal access to cancer treatment support, violating the equal rights of citizens in non-notifying states.
• Article 47 (DPSP): Directs the State to "regard the raising of the level of nutrition and the standard of living of its people and the improvement of public health as among its primary duties." This DPSP, read with Article 21, forms the constitutional foundation for the court's intervention.
• Article 32: Empowers the Supreme Court to enforce fundamental rights — the PIL is filed under this Article, invoking the Court's writ jurisdiction to protect the right to health.

Legal Framework

• Epidemic Diseases Act, 1897 (as amended 2020): The colonial-era law dealing with dangerous epidemic diseases. Sections 2 and 2A give state governments powers to prescribe measures against spread of dangerous diseases — a limited basis for notifying communicable diseases. It does not directly mandate cancer notification.
• National Health Policy, 2017: Sets targets for reducing premature mortality from NCDs (including cancer) by 25% by 2025. Recommends strengthening cancer registries and screening programmes.
• Prevention and Control of Non-Communicable Diseases Act (proposed): India has not yet enacted a standalone national NCD law. The absence of such legislation is one reason cancer notification is inconsistent.
• Parliamentary Standing Committee recommendation: The basis for the 17 states that had already notified cancer. The SC order now builds on this recommendation and gives it quasi-mandatory force through its direction to the remaining 19 states/UTs.
• Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996): SC held that failure to provide emergency medical treatment violates Article 21 — precedent for right to health as part of Article 21.

Institutional Framework

• Ministry of Health and Family Welfare (MoHFW): Nodal Central ministry for public health policy; questioned by SC on why mandatory guidelines were not issued.
• Indian Council of Medical Research (ICMR): Manages the National Cancer Registry Programme (NCRP); the primary body for cancer data in India.
• National Cancer Registry Programme (NCRP): Network of population-based and hospital-based cancer registries across India; official cancer data source.
• State Health Departments: Responsible for issuing state-level notifiable disease notifications under respective state public health laws.
• National Centre for Disease Informatics and Research (NCDIR): Under ICMR; coordinates cancer registry activities and data analysis.
• Supreme Court of India: Exercising PIL jurisdiction under Article 32 to enforce the right to health as part of Article 21.

Economic Dimensions

Cancer imposes a heavy economic burden on India's households and the public health system. A 2023 Lancet Oncology study estimated that India's total economic cost of cancer was several lakh crore rupees annually, factoring in treatment costs, lost productivity, and informal caregiver burden. Out-of-pocket expenditure on cancer treatment is catastrophic for most households, with cancer being a leading driver of medical impoverishment.

Notification will enable the Central Government and state governments to plan and allocate budgets more precisely for cancer screening, diagnosis, and treatment infrastructure — improving the efficiency of health spending under schemes like Ayushman Bharat (PM-JAY) and National Cancer Grid hospitals. Better data will also strengthen India's case for international health funding and research collaborations.

Social Dimensions

Cancer disproportionately affects women (cervical cancer, breast cancer are leading killers in low-income households), tobacco users (oral, lung cancers dominate in rural India), and communities with poor access to tertiary healthcare. Cancer notification will enable targeted early detection camps in underserved districts, improving health equity across gender, caste, and income groups.

The order has particular significance for tribal communities in states like Jharkhand, Chhattisgarh, and Odisha, where cancer incidence linked to industrial pollution and tobacco use is high but healthcare access is limited. Cancer notification will help quantify the burden and attract resources to these communities.

Challenges

• Public health as a State subject: Health is primarily in the Concurrent List (Entry 6, List III), with significant State autonomy. Mandatory central guidelines may face political and legal resistance from states asserting their legislative competence.
• Healthcare infrastructure gaps: Even after notification, accurate reporting requires functioning diagnostic infrastructure (pathology labs, oncology units) in district hospitals — which many states lack.
• Stigma and privacy: Cancer notification raises concerns about patient privacy and social stigma, particularly in rural areas. A legal framework for data protection in notifiable disease reporting is lacking.
• Data quality and reporting burden: Private hospitals and clinics, which handle a significant share of cancer cases, may resist additional reporting obligations without clear enforcement mechanisms.
• Follow-through: Compliance affidavits do not guarantee actual state action — implementation monitoring will be essential.

Government Initiatives

• Ayushman Bharat PM-JAY: Covers cancer treatment for eligible beneficiaries under the Rs 5 lakh annual insurance cover; however, access depends on timely diagnosis.
• National Programme for Non-Communicable Diseases (NP-NCD): Provides for cancer, diabetes, and cardiovascular disease screening and management at district hospitals.
• National Cancer Grid (NCG): Network of 250+ cancer centres across India, coordinated by Tata Memorial Centre, to standardise cancer treatment.
• Rashtriya Arogya Nidhi: Provides financial assistance to BPL patients suffering from life-threatening diseases including cancer.
• National Cancer Registry Programme (NCRP): Maintains 30 population-based cancer registries; cancer notification will feed into and strengthen this system.

Way Forward

• The Central Government should issue mandatory national guidelines under its executive powers and coordinate with states through the National Health Mission framework to ensure uniform cancer notification across all 36 states and UTs.
• Parliament should consider enacting a Prevention and Control of Non-Communicable Diseases Act — a national law that provides a statutory basis for NCD notification, data collection, and treatment protocols.
• A robust digital cancer registry platform integrated with Ayushman Bharat Digital Mission (ABDM) health records should be developed, so notification auto-populates from diagnostic reports with appropriate privacy safeguards.
• Privacy protections analogous to those in the Digital Personal Data Protection Act, 2023 should be extended to cancer registry data, building patient trust in the notification system.
• Public and private hospital participation in notification should be incentivised — linking compliance to accreditation (NABH) status and insurance empanelment (PM-JAY) would be effective levers.
• The Law Commission of India could examine the need for a comprehensive national public health law to replace the outdated Epidemic Diseases Act, 1897 and provide a modern legislative basis for NCD management.

Possible Mains Questions

1. "Declaring cancer a notifiable disease is as much a constitutional imperative as a public health necessity." Critically examine the Supreme Court's directions in the context of the right to health under Article 21, India's cancer burden, and the challenges of Centre-state coordination in public health. (GS-II, 250 words)
2. Discuss the distinction between communicable and non-communicable notifiable diseases in India. What institutional reforms are needed to build a robust national disease surveillance system? (GS-II, 150 words)

Possible Prelims MCQs

1. Q: Which constitutional provision has the Supreme Court most directly invoked to establish a "right to health" in India?
   Answer: Article 21 (right to life and personal liberty), interpreted to include the right to health and emergency medical care.
2. Q: Under which Schedule of the Constitution is "public health and sanitation" listed as a subject?
   Answer: Concurrent List (List III), Entry 6 — Public health and sanitation. Both Centre and states can legislate on this subject.

Essay Dimensions

1. India's silent cancer crisis: why public health surveillance must go beyond communicable diseases.
2. The right to health as a constitutional obligation: judicial activism and legislative gaps in India's NCD governance.
3. Data as a public good: the case for a national cancer registry underpinned by privacy-respecting notification.
4. Universal health coverage and the cancer burden: closing the gap between policy and practice in India.
5. Federalism and public health: resolving Centre-state tensions in India's fight against non-communicable diseases.

Interview Questions

1. What is a notifiable disease, and why is declaring cancer as one significant for India's public health system?
2. How has the Supreme Court interpreted Article 21 to encompass the right to health? Cite landmark judgments.
3. What are the challenges of achieving uniform public health policy in India given that health is in the Concurrent List?
4. What institutional mechanisms does India have for cancer data collection, and how will notification strengthen them?
5. How does the Digital Personal Data Protection Act, 2023 interact with disease notification and health registry requirements?

FAQ

What does it mean to declare cancer a notifiable disease?

It means healthcare providers (doctors, hospitals, labs) are legally required to report every new cancer diagnosis to the state government health authority. This enables the government to track the real burden of cancer, plan screening programmes, allocate resources, and link patients to government treatment schemes.

Why hasn't cancer been notified uniformly across India until now?

Public health is a Concurrent List subject, meaning each state has its own public health laws and can choose which diseases to notify. Despite a parliamentary standing committee recommendation, only 17 of 36 states and UTs had acted. The absence of a central mandate and enforcement mechanism led to patchy implementation.

What is the constitutional basis for the Supreme Court's intervention?

The PIL invokes Articles 14 (equality) and 21 (right to life, including right to health) of the Constitution. The Court exercised its jurisdiction under Article 32 (right to constitutional remedies) to direct states to take public health action that protects citizens' fundamental rights to timely diagnosis and equitable treatment.

Further Reading

• Articles 14, 21, 32, and 47 — Constitution of India (indiacode.nic.in)
• National Cancer Registry Programme — ICMR-NCDIR (ncdirindia.org)
• National Health Policy 2017 — Ministry of Health and Family Welfare
• Epidemic Diseases Act, 1897 (as amended 2020) — India Code
• Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996) — Supreme Court